Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: FTSE set for positive return from Christmas break

(Sharecast News) - London stocks were set to return from the Christmas break in the green on Wednesday, following a late Santa rally for Wall Street overnight. The FTSE 100 was expected to open 41 points higher at 7,746.90, having closed ahead 0.04% at the end of its truncated session on 22 December.

"Yesterday was a slow day where the dovish Fed expectations continued to remain in the driver seat and drive the US stock and bond markets higher, while many other markets were peacefully sleeping," said Swissquote Bank senior analyst Ipek Ozkardeskaya.

"Buyers rushed into the US Treasury's bond auctions yesterday to close in some good deals before the year ends on expectations that the Federal Reserve (Fed) will start chopping the rates by spring."

Ozkardeskaya said that according to Bloomberg, the US Treasury's 52-week bill auction saw record demand from indirect bidders - a group including foreign central banks - while the six-month bill saw 71.6% demand, the third biggest in history.

"This means that investors expect the yields to come significantly lower in the next six to 12 months.

"Consequently, the US two-year yield slipped below the 4.3% mark, [and] the US 10-year yield steadied below the 3.90% level."

The Dow Jones Industrial Average closed 159.36 points higher overnight, extending the gains it recorded on Friday as market participants cheered a recent surprise reading of the Federal Reserve's favourite inflation gauge.

In economic news, the slide in industrial profits in China slowed significantly overnight, with November seeing a 4.4% fall compared to the prior month's 7.8% plunge.

On the equities front in London, AstraZeneca announced that it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Under the terms of the deal, AstraZeneca would acquire all of Gracell's shares at $2 per share in cash, plus a non-tradable contingent value right of $0.30 per ordinary share payable upon achievement of a specified regulatory milestone.

The upfront cash portion represented a 62% premium to Gracell's closing market price on 22 December.

Elsewhere, HgCapital Trust said its manager Hg had agreed to a partial sale of its investment in IRIS Software Group to LGP, a Los Angeles-based private equity firm.

The transaction's financial terms were not disclosed, but valued HgCapital Trust's investment in IRIS at around £99.8m, with a net distribution of approximately £42.1m to the trust.

Following the sale, its exposure to IRIS would be £57.7m, representing 2.5% of its net asset value as of 30 September, with HgCapital Trusts's available liquid resources estimated at £705m.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Europe open: Shares make strong start ahead of ECB rate call
(Sharecast News) - European markets made a strong start to the week as investors look ahead a European Central Bank's interest rate decision on Thursday, widely expected to be a 25 basis point cut.
London pre-open: Stocks seen up ahead of manufacturing data
(Sharecast News) - London stocks were set to rise at the open on Monday as investors eyed the latest UK manufacturing reading.
Asia report: Shares rally on rate cut hopes, China Caixin PMI
(Sharecast News) - Asian share markets rallied on Monday, as investors awaited an expected rate cut from the European Central Bank, while a positive factory activity survey in China also boosted sentiment.
US close: Dow, S&P 500 jump after data hints at economic slowdown
(Sharecast News) - US stocks rallied into the close on Friday with the Dow and S&P 500 rising strongly after economic data showed a moderation in consumer spending growth and the slowest monthly gain in prices so far this year - two factors that could increase the pressure on the Federal Reserve to start cutting interest rates.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.